Mar­ket­ingRx roundup: Pfiz­er switch­es up ad­ver­tis­ing du­ties; No­vo Nordisk’s Ozem­pic gets spoofed on SNL

Pfiz­er moves cre­ative ad­ver­tis­ing work to Pub­li­cis: Less than a year af­ter Pfiz­er con­sol­i­dat­ed ad agency re­la­tion­ships un­der a dual sys­tem of re­spon­si­bil­i­ties, it’s chang­ing tacks and mov­ing the bulk of its cre­ative work from IPG Health and FCB to Pub­li­cis. Pre­vi­ous­ly in May, Pfiz­er named IPG as its lead cre­ative part­ner and Pub­li­cis Groupe to head up me­dia, tech­nol­o­gy and pro­duc­tion af­ter a three-month re­view. The agency change­up fol­lows Pfiz­er’s cor­po­rate brand de­but Su­per Bowl com­mer­cial, cre­at­ed by Pfiz­er and a col­lab­o­ra­tion of Pub­li­cis agen­cies. Pfiz­er said in a state­ment to End­points News that it is “com­mit­ted to the flex­i­ble, two-agency part­ner­ship” with both groups.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER